Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor

Laprairie, R B, Bagher, A M, Kelly, M E M, Denovan‐Wright, E M·2015·British Journal of Pharmacology

DOI 10.1111/bph.13250

Cited by (1,000)

Items 501–600 of 1,000

The United Chemicals of Cannabis: Beneficial Effects of Cannabis Phytochemicals on the Brain and Cognition
Katrina Weston–Green · 2019 · IntechOpen eBooks
Single and Repeated Exposure to Cannabidiol Differently Modulate BDNF Expression and Signaling in the Cortico-Striatal Brain Network
Francesca Mottarlini, Marco Fumagalli, Fernando Castillo Díaz, Stefano Piazza, Giorgia Targa, Enrico Sangiovanni, Barbara Pacchetti, Mikael Hans Sodergren, Mario Dell’Agli, Fabio Fumagalli et al. · 2022 · Biomedicines
Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis
Albert Stuart Reece, Gary Kenneth Hulse · 2022 · International Journal of Environmental Research and Public Health
Argentination: A Silver Bullet for Cannabinoid Separation by Differential Mobility Spectrometry
Christian Ieritano, Patrick Thomas, W. Scott Hopkins · 2023 · Analytical Chemistry
A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders
Oluwadara Pelumi Omotayo, Yolandy Lemmer, Shayne Mason · 2024 · Journal of Cannabis Research
Cannabinoids and Sleep: Exploring Biological Mechanisms and Therapeutic Potentials
Martina D’Angelo, Luca Steardo · 2024 · International Journal of Molecular Sciences
Development of cannabidiol as a treatment for severe childhood epilepsies
Claire Michelle Williams, Gary J. Stephens · 2020 · British Journal of Pharmacology
Antinociception mechanisms of action of cannabinoid-based medicine: an overview for anesthesiologists and pain physicians
Samer Narouze · 2020 · Regional Anesthesia & Pain Medicine
Transcriptomic Changes and the Roles of Cannabinoid Receptors and PPARγ in Developmental Toxicities Following Exposure to Δ9-Tetrahydrocannabinol and Cannabidiol
Zacharias Pandelides, Neelakanteswar Aluru, Cammi Thornton, Haley E Watts, Kristine L. Willett · 2021 · Toxicological Sciences
Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies
D. Daldegan-Bueno, L. O. Maia, M. Glass, Didier Jutras-Aswad, B. Fischer · 2021 · Psychopharmacology
Efficacy of the FDA-approved cannabidiol on the development and persistence of temporal lobe epilepsy and complex focal onset seizures
Doodipala Samba Reddy, Robert H. Mbilinyi, Sreevidhya Ramakrishnan · 2022 · Experimental Neurology
Does modulation of the endocannabinoid system have potential therapeutic utility in cerebellar ataxia?
Gary J. Stephens · 2016 · The Journal of Physiology
Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy
MariaLuisa Vigano, Lixing Wang, Alia As’sadiq, Suzanne Samarani, Ali Ahmad, Cecilia Theresa Costiniuk · 2025 · Frontiers in Immunology
Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights
Sabrina Bimonte, Giuseppe Palma, Marco Cascella, Arturo Cuomo · 2023 · Anticancer Research
Cannabinoids: Emerging sleep modulator
Zhen Xuen Brandon Low, Xin Ru Lee, Tomoko Soga, Bey Hing Goh, Deepa Alex, Yatinesh Kumari · 2023 · Biomedicine & Pharmacotherapy
Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB1 Receptor Antagonists after the Fall
Taryn Bosquez-Berger, Gergő Szanda, Alex J. Straiker · 2023 · Drugs and Drug Candidates
Single and Combined Effects of Cannabigerol (CBG) and Cannabidiol (CBD) in Mouse Models of Oxaliplatin-Associated Mechanical Sensitivity, Opioid Antinociception, and Naloxone-Precipitated Opioid Withdrawal
Sean A. Hayduk, Amanda C. Hughes, Rachel L. Winter, Mia Milton, Sara Jane Ward · 2024 · Biomedicines
Potential of CBD Acting on Cannabinoid Receptors CB1 and CB2 in Ischemic Stroke
Iu Raïch, Jaume Lillo, Rafael Rivas‐Santisteban, Joan Biel Rebassa, Toni Capó, Montserrat Santandreu, Erik Cubeles-Juberias, Irene Reyes‐Resina, Gemma Navarro · 2024 · International Journal of Molecular Sciences
The Transcriptomic Analysis of NSC-34 Motor Neuron-Like Cells Reveals That Cannabigerol Influences Synaptic Pathways: A Comparative Study with Cannabidiol
Agnese Gugliandolo, Serena Silvestro, Luigi Chiricosta, Federica Pollastro, Placido Bramanti, Emanuela Mazzon · 2020 · Life
Structural revision of a Wnt/β-catenin modulator and confirmation of cannabielsoin constitution and configuration
Angelina Z. Monroe, William H. Gordon, Jared S. Wood, Gary E. Martin, Jeremy B. Morgan, Robert Thomas Williamson · 2021 · Chemical Communications
An Evaluation of Understudied Phytocannabinoids and Their Effects in Two Neuronal Models
Alex J. Straiker, Sierra Wilson, Wesley Corey, Michaela Dvořáková, Taryn Bosquez-Berger, Joye X. Tracey, Caroline M. Wilkowski, Kathleen Ho, Jim Wager‐Miller, Ken Mackie · 2021 · Molecules
Ketamine-induced neurotoxicity is mediated through endoplasmic reticulum stress in vitro in STHdhQ7/Q7 cells
Nicolette Rigg, Fahed A. Abu-Hijleh, Vidhi Patel, Ram K. Mishra · 2022 · NeuroToxicology
How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases
Sylwia Dziemitko, Ewa Harasim‐Symbor, Adrian Chabowski · 2023 · Therapeutic Advances in Chronic Disease
Craniofacial neuralgias
Sheryl Katta-Charles · 2020 · Neurorehabilitation
Cannabinoid Signaling in Auditory Function and Development
Sumana Ghosh, Kendra L. Stansak, Bradley J. Walters · 2021 · Frontiers in Molecular Neuroscience
Cannabidiol Prevents Heart Failure Dysfunction and Remodeling Through Preservation of Mitochondrial Function and Calcium Handling
Gerardo García‐Rivas, Omar Lozano, Judith Bernal‐Ramírez, Christian Silva‐Platas, Felipe Salazar‐Ramírez, Abraham Méndez‐Fernández, Carolina A. Morales‐Ochoa, Hugo Alves‐Figueiredo, Martin Ramos-González, Néstor Rubio‐Infante et al. · 2025 · JACC Basic to Translational Science
Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials
Caroline Vuilleumier, Norbert Scherbaum, Udo Bonnet, Patrik Roser · 2022 · Frontiers in Psychiatry
Dose-Dependent Antidepressant-Like Effects of Cannabidiol in Aged Rats
Elena Hernández‐Hernández, María Julia García-Fuster · 2022 · Frontiers in Pharmacology
A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021
Liu Liu, Jianxing Liu, Ming Zhao, Meiming Cai, Fanzhang Lei, Xiaofeng Zeng, Bofeng Zhu · 2022 · Frontiers in Pharmacology
Cannabidiol treatment improves metabolic profile and decreases hypothalamic inflammation caused by maternal obesity
Fernanda da Silva Rodrigues, Jeferson Jantsch, Gabriel de Farias Fraga, Victor Silva Dias, Sarah Carobini Werner de Souza Eller, Tiago Franco de Oliveira, Márcia Giovenardi, Renata Padilha Guedes · 2023 · Frontiers in Nutrition
Design and Synthesis of Cannabinoid 1 Receptor (CB1R) Allosteric Modulators: Drug Discovery Applications
Abhijit Kulkarni, Sumanta Garai, David R. Janero, Ganesh A. Thakur · 2017 · Methods in enzymology on CD-ROM/Methods in enzymology
Perspectives of cannabis-based medicines in a view of pharmacokinetic studies of Δ9-THC and CBD in humans
Magdalena Kaszewska, Katarzyna Woźniczka, Katarzyna Sztormowska-Achranowicz, Agnieszka Mosińska, Václav Trojan, Patrik Schreiber, Nikolas Balog, Tomasz Bączek, Anna Roszkowska · 2025 · Biomedicine & Pharmacotherapy
Cannabidiol decreases motivation for cocaine in a behavioral economics paradigm but does not prevent incubation of craving in mice
Laia Alegre-Zurano, Paula Berbegal-Sáez, Miguel Ángel Luján, Lídia Cantacorps, Ana Martín‐Sánchez, Alba García-Baos, Olga Valverde · 2022 · Biomedicine & Pharmacotherapy
Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice
Barkha J. Yadav-Samudrala, Benjamin Land Gorman, Karenna M. Barmada, Havilah Ravula, Caitlin J. Huguely, E. Diane Wallace, Michelle R. Peace, Justin L. Poklis, Wei Jiang, Sylvia Fitting · 2024 · Frontiers in Neuroscience
Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells
Yutao Li, Amit Sharma, Michèle J. Hoffmann, Dirk Skowasch, Markus Essler, Hans Weiher, Ingo G.H. Schmidt‐Wolf · 2024 · Frontiers in Immunology
Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects
Zonghao Hu, Zishun Qin, Jinhong Xie, Yue Qu, Lihua Yin · 2024 · Biomedicine & Pharmacotherapy
Schizophrenia and drug addiction comorbidity: recent advances in our understanding of behavioural susceptibility and neural mechanisms
Victoria Menne, Rose Chesworth · 2020 · Neuroanatomy and Behaviour
Cannabinoids, Inner Ear, Hearing, and Tinnitus: A Neuroimmunological Perspective
Paola Perin, Alex Mabou Tagne, Paolo Enrico, Franca Marino, Marco Cosentino, Roberto Pizzala, Cinzia Boselli · 2020 · Frontiers in Neurology
Cannabidiol prevents lipopolysaccharide-induced sickness behavior and alters cytokine and neurotrophic factor levels in the brain
Pedro Augusto Lopes Tito, Túlio Cézar de Souza Bernardino, Paula Maria Quaglio Bellozi, Maria Carolina Machado da Silva, Aline Silva de Miranda, Érica Leandro Marciano Vieira, Fabrício A. Moreira, András Palotás, Antônio Carlos Pinheiro de Oliveira, Helton José Reis · 2021 · Pharmacological Reports
Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?
Kristine Rømer Thomsen, Birgitte Thylstrup, Emily A. Kenyon, Rachel Lees, Lone Baandrup, Sarah W. Feldstein Ewing, Tom P. Freeman · 2021 · Neuroscience & Biobehavioral Reviews
Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents
Bryan W. Jenkins, Shoshana Buckhalter, Melissa L. Perreault, Jibran Younis Khokhar · 2021 · Schizophrenia Bulletin Open
The Metabolic Efficacy of a Cannabidiolic Acid (CBDA) Derivative in Treating Diet- and Genetic-Induced Obesity
Elad Ben-Cnaan, Anna Permyakova, Shahar Azar, Shira Hirsch, Saja Baraghithy, Liad Hinden, Joseph Tam · 2022 · International Journal of Molecular Sciences
Understanding feeling “high” and its role in medical cannabis patient outcomes
Sarah See Stith, Xiaoxue Li, Franco Brockelman, Keenan Keeling, Branden Hall, Jacob Miguel Vigil · 2023 · Frontiers in Pharmacology
Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial
Edward Chesney, Dominic Oliver, Ananya Sarma, Ayşe Doğa Lamper, Ikram Slimani, Millie Lloyd, Alex M. Dickens, Michael Welds, Matilda Kråkström, Irma Gasparini-Andre et al. · 2025 · Neuropsychopharmacology
Cannabidiol in low back pain: scientific rationale for clinical trials in low back pain
Gabor Zoltan Xantus, László Závori, Candice Matheson, Valéria Anna Gyarmathy, Laszlo M Fazekas, Péter Kanizsai · 2021 · Expert Review of Clinical Pharmacology
Cannabidiol attenuates insular activity during motivational salience processing in patients with early psychosis
Brandon Gunasekera, Robin Paul Wilson, Aisling O’Neill, Grace Blest‐Hopley, Owen O’Daly, Sagnik Bhattacharyya · 2022 · Psychological Medicine
Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin
Kenneth B. Walsh, Andrea E. Holmes · 2022 · Receptors
Impact of cannabidiol on reward- and stress-related neurocognitive processes among individuals with opioid use disorder: A pilot, double-blind, placebo-controlled, randomized cross-over trial
Joji Suzuki, Sara Prostko, Veronica Szpak, Peter Ray Chai, Primavera A. Spagnolo, Ruth E. Tenenbaum, Saeed Ahmed, Roger D. Weiss · 2023 · Frontiers in Psychiatry
The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer’s Disease
Václav Trojan, Leoš Landa, Alexandra Šulcová, Jiří Slíva, Radovan Hřib · 2023 · Biomolecules
Cannabidiol Exposure During Gestation Leads to Adverse Cardiac Outcomes Early in Postnatal Life in Male Rat Offspring
Kendrick Lee, Sebastian Vanin, Mina G. Nashed, Mohammed Halit Sarikahya, Steven R. Laviolette, David R.C. Natale, Daniel Barry Hardy · 2024 · Cannabis and Cannabinoid Research
Cannabidiol protects C2C12 myotubes against cisplatin-induced atrophy by regulating oxidative stress
Olivier Le Bacquer, Phelipe Sanchez, Véronique Patrac, César Rivoirard, Nicolas Saroul, Christophe Giraudet, Ayhan Kocer, Stéphane Walrand · 2024 · American Journal of Physiology-Cell Physiology
Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen
Kennadi Johnson, Abby Jones Weldon, Melissa A. Burmeister · 2024 · Frontiers in Psychiatry
Ion channels and G protein-coupled receptors: Cannabidiol actions on disorders of excitability and synaptic excitatory-inhibitory ratio
Richard W. Tsien, Evan C. Rosenberg · 2025 · Molecular Pharmacology
The Endocannabinoid System and Synthetic Cannabinoids in Preclinical Models of Seizure and Epilepsy
Anna-Maria Smolyakova, Ayat Zagzoog, Asher L. Brandt, Tallan Black, Kawthar A. Mohamed, Robert B. Laprairie · 2019 · Journal of Clinical Neurophysiology
Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway
Baoyu Shen, Dongxian Zhang, Xiaofeng Zeng, Lina Guan, Genmeng Yang, Liu Liu, Jian An Huang, Yuanyuan Li, Shijun Hong, Lihua Li · 2022 · Psychopharmacology
Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence
Riccardo Bortoletto, Matteo Balestrieri, Sagnik Bhattacharyya, Marco Colizzi · 2022 · Brain Sciences
Modulation of Recombinant Human T-Type Calcium Channels by Δ 9 -Tetrahydrocannabinolic Acid In Vitro
Somayeh Mirlohi, Chris Bladen, Marina Santiago, Mark A. Connor · 2021 · Cannabis and Cannabinoid Research
Differential Enantiomer-Specific Signaling of Cannabidiol at CB1 Receptors
Taryn Bosquez-Berger, Sierra Wilson, Christos Iliopoulos‐Tsoutsouvas, Shan Hao Jiang, Jim Wager‐Miller, Spyros P. Nikas, Ken Mackie, Alexandros Makriyannis, Alex J. Straiker · 2022 · Molecular Pharmacology
Different responses of repetitive behaviours in juvenile and young adult mice to Δ9‐tetrahydrocannabinol and cannabidiol may affect decision making for Tourette syndrome
Victoria Gorberg, Peter J. A. McCaffery, Sharon Anavi‐Goffer · 2020 · British Journal of Pharmacology
Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review
Francesco Bartoli, Ilaria Riboldi, Bianca Bachi, Angela Calabrese, Federico Moretti, Cristina Crocamo, Giuseppe Carrà · 2021 · Journal of Clinical Medicine
Exploring Psilocybe spp. mycelium and fruiting body chemistry for potential therapeutic compounds
Waldbillig, Adam, Baranova, Maria, Neumann, Sarah, Andrade, Jonathan, Sidhu, Sharan · 2023 · Frontiers in Fungal Biology
Presynaptic nigral GPR55 receptors stimulate [ 3 H]‐GABA release through [ 3 H]‐cAMP production and PKA activation and promote motor behavior
Rodolfo Sánchez‐Zavaleta, José Arturo Ávalos‐Fuentes, Antonio Valentín González‐Hernández, Sergio Recillas‐Morales, Francisco Javier Paz‐Bermúdez, Gerardo Leyva‐Gómez, Hernán Cortés, Benjamín Florán · 2022 · Synapse
Human osteoclasts in vitro are dose dependently both inhibited and stimulated by cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC)
Simone Snitgård Rosendal Nielsen, Juliana Alicja Zink Pedersen, Neha Sharma, Pernille K. Wasehuus, Morten Steen Hansen, Anaïs M.J. Møller, Xenia G. Borggaard, Alexander Rauch, Morten Frost, Teis Esben Søndergaard et al. · 2024 · Bone
Cannabidiol improves maternal obesity-induced behavioral, neuroinflammatory and neurochemical dysfunctions in the juvenile offspring
Fernanda da Silva Rodrigues, Jeferson Jantsch, Gabriel de Farias Fraga, Vitória Luiza de Camargo Milczarski, Victor Silva Dias, Camila Scheid, Josias de Oliveira Merib, Marcia Giovernardi, Renata Padilha Guedes · 2024 · Brain Behavior and Immunity
Oral pre‐ and early postnatal cannabis exposure disinhibits ventral tegmental area dopamine neuron activity but does not influence cocaine preference in offspring in mice
Colleen S. Peterson, Samantha L. Baglot, Nada A. Sallam, Sarah Mina, Matthew N. Hill, Stephanie L. Borgland · 2024 · Journal of Neuroscience Research
A comprehensive update on cannabidiol, its formulations and drug delivery systems
Surojit Banerjee, Vikas Anand Saharan, Debadri Banerjee, Veerma Ram, Hitesh Kulhari, Deep Pooja, Anupama Singh · 2024 · Phytochemistry Reviews
Unveiling the Potential of Phytocannabinoids: Exploring Marijuana’s Lesser-Known Constituents for Neurological Disorders
Balapal S. Basavarajappa, Shivakumar Subbanna · 2024 · Biomolecules
Determination of the Negative Allosteric Binding Site of Cannabidiol at the CB1 Receptor: A Combined Computational and Site-Directed Mutagenesis Study
Pankaj Pandey, Ayat Zagzoog, Robert B. Laprairie, William M. Neal, Robert J. Doerksen, Amar Gopal Chittiboyina · 2025 · ACS Chemical Neuroscience
Combined effects of cannabidiol and Δ9-tetrahydrocannabinol alleviate migraine-like symptoms in mice
Erik Zorrilla, Georgii Krivoshein, Adisa Kuburas, Maarten Schenke, Cassandra L. Piña, Sandra H. van Heiningen, Jayme S. Waite, Anisa Dehghani, William C. Castonguay, Harold C. Flinn et al. · 2025 · Cephalalgia
An Overview of the Potential for Pharmacokinetic Interactions Between Drugs and Cannabis Products in Humans
Dolly Andrea Caicedo, Clara Pérez‐Mañá, Magı́ Farré, Esther Papaseit · 2025 · Pharmaceutics
A closer look at cannabimimetic terpenes, polyphenols, and flavonoids: a promising road forward
RafaelCypriano Dutra, Juliana Cavalli · 2020 · Neural Regeneration Research
New Insights Into Peptide Cannabinoids: Structure, Biosynthesis and Signaling
Agustín Riquelme-Sandoval, Caio Oliveira de Sá-Ferreira, Leo M. Miyakoshi, Cecilia Hedin‐Pereira · 2020 · Frontiers in Pharmacology
Cannabinoids: A New Perspective on Epileptogenesis and Seizure Treatment in Early Life in Basic and Clinical Studies
Angélica Vega-García, Iris Angélica Feria-Romero, Anais García-Juárez, Ana Ch. Munguia-Madera, Alexia V. Montes-Aparicio, Esli Zequeida-Muñoz, Estefany Garcia-Albavera, Sandra Adela Orozco-Suárez · 2021 · Frontiers in Behavioral Neuroscience
Alterations in Electroencephalography Theta as Candidate Biomarkers of Acute Cannabis Intoxication
Christian Richard, Jared Poole, Marissa McConnell, Amir H. Meghdadi, Marija Stevanović Karić, Greg Rupp, Abigail Fink, Rose Schmitt, Timothy L. Brown, Chris Berka · 2021 · Frontiers in Neuroscience
Effects of Tetrahydrocannabinol and Cannabidiol on Brain-Derived Neurotrophic Factor and Tropomyosin Receptor Kinase B Expression in the Adolescent Hippocampus
Joanna Winstone, Hana S. Shafique, Madeleine E. Clemmer, Ken Mackie, Jim Wager‐Miller · 2022 · Cannabis and Cannabinoid Research
A Clinical Framework for Assessing Cannabis-Related Impairment Risk
Caroline A. MacCallum, Lindsay A. Lo, Carly A. Pistawka, April L. Christiansen, Michael R. Boivin, Melissa Snider-Adler · 2022 · Frontiers in Psychiatry
Phytocannabinoids Reduce Inflammation of Primed Macrophages and Enteric Glial Cells: An In Vitro Study
Gal Cohen, Ofer Gover, Betty Schwartz · 2023 · International Journal of Molecular Sciences
Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention
Eugene L. Scharf · 2017 · Cannabis and Cannabinoid Research
Binding Characterization of GPCRs-Modulator by Molecular Complex Characterizing System (MCCS)
Zhiwei Feng, Tianjian Liang, Siyi Wang, Maozi Chen, Tianling Hou, Jack Jiagang Zhao, Hui Chen, Yuehan Zhou, Xiang‐Qun Xie · 2020 · ACS Chemical Neuroscience
Identification and Characterization of Cannabidiol as an OX1R Antagonist by Computational and In Vitro Functional Validation
Rosa Maria Vitale, Fabio Arturo Iannotti, Aniello Schiano Moriello, Lea Tunisi, Fabiana Piscitelli, Ranjev Savopoulos, Luigia Cristino, Luciano De PETROCELLIS, Pietro Amodeo, Roy Gray et al. · 2021 · Biomolecules
Thoughtfully Integrating Cannabis Products Into Chronic Pain Treatment
Kevin F. Boehnke, Christopher L. Wu, Daniel Joseph Clauw · 2023 · Anesthesia & Analgesia
Preparation and Characterization of Hydroxypropyl Methylcellulose/Polyvinyl Alcohol Mucoadhesive Buccal Film of Cannabidiol
Wacharakul Laoasoke, Chasuda Choipang, Sonthaya Chaiarwut, Orawan Suwantong, Piyachat Chuysinuan, Supanna Techasakul, Pakakrong Sangsanoh, Pitt Supaphol · 2024 · Journal of Polymers and the Environment
UK Medical Cannabis Registry: Assessment of clinical outcomes in patients with insomnia
Kavyesh Vivek, Zekiye Karagozlu, Simon Erridge, Carl Holvey, Ross Coomber, James Rucker, Mark W. Weatherall, Mikael Hans Sodergren · 2024 · Brain and Behavior
Cannabidiol induces systemic analgesia through activation of the PI3Kγ/nNOS/NO/KATP signaling pathway in neuropathic mice. A KATP channel S-nitrosylation-dependent mechanism
Douglas Lamounier de Almeida, Renata Cristina Mendes Ferreira, Flávia Cristina de Sousa Fonseca, Daniel Portela Dias Machado, Danielle Diniz Aguiar, Francisco Silveira Guimarães, Igor Dimitri Gama Duarte, Thiago Roberto Lima Romero · 2024 · Nitric Oxide
Indomethacin Enhances Type 1 Cannabinoid Receptor Signaling
Robert B. Laprairie, Kawthar A. Mohamed, Ayat Zagzoog, Melanie E. M. Kelly, Lesley Stevenson, Roger G. Pertwee, Eileen M. Denovan‐Wright, Ganesh A. Thakur · 2019 · Frontiers in Molecular Neuroscience
Cannabinoids as an Emerging Therapy for Posttraumatic Stress Disorder and Substance Use Disorders
Jacob Cohen, Zelan Wei, Jonathan Phang, Robert B. Laprairie, Yanbo Zhang · 2019 · Journal of Clinical Neurophysiology
The endocannabinoid system as a therapeutic target for schizophrenia: Failures and potentials
Alexandre Seillier · 2021 · Neuroscience Letters
Effects of phytocannabinoids on heart rate variability and blood pressure variability in female post-concussion syndrome patients: case series
Jyotpal Singh, Lanishen Bhagaloo, Jarosław Piskorski, J. Patrick Neary · 2021 · Canadian Journal of Physiology and Pharmacology
Differential Effects of Cannabidiol and a Novel Cannabidiol Analog on Oxycodone Place Preference and Analgesia in Mice: an Opioid Abuse Deterrent with Analgesic Properties
Hannah M. Harris, Waseem Gul, Mahmoud A. ElSohly, Kenneth J. Sufka · 2021 · Cannabis and Cannabinoid Research
Enhancing axonal myelination in seniors: A review exploring the potential impact cannabis has on myelination in the aged brain
Colin J. Murray, Haley A. Vecchiarelli, Marie‐Ève Tremblay · 2023 · Frontiers in Aging Neuroscience
Targeting the endocannabinoid system: Structural determinants and molecular mechanism of allosteric modulation
Jiayi Yuan, Bo Ram Yang, Guanyu Hou, Xiang‐Qun Xie, Zhiwei Feng · 2023 · Drug Discovery Today
Sex and estrous cycle-linked differences in the effect of cannabidiol on panic-like responding in rats and mice
Paloma Molina Hernandes, Matheus Fitipaldi Batistela, Jefferson Manoel Nascimento‐Silva, Alana Tercino Frias, Melina Matthiesen, Alline Cristina Campos, T.A. Lovick, Hélio Zangrossi · 2023 · Behavioural Brain Research
Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials
Annelieke R. Müller, Bibiche den Hollander, Peter M. van de Ven, Kit C. B. Roes, Lisa Geertjens, Hilgo Bruining, Clara van Karnebeek, Floor E. Jansen, Marie‐Claire Y. de Wit, Leontine W. ten Hoopen et al. · 2024 · BMC Psychiatry
The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders
Roberto Coccurello, Maria Cristina Marrone, Mauro Maccarrone · 2022 · Frontiers in Pharmacology
Development of a Rapid LC-MS/MS Method for the Quantification of Cannabidiol, Cannabidivarin, Δ9-Tetrahydrocannabivarin, and Cannabigerol in Mouse Peripheral Tissues
Fabiana Piscitelli, Ester Pagano, Anna Lauritano, Angelo Antonio Izzo, Vincenzo Di Marzo · 2017 · Analytical Chemistry
The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics
Ahmed, Mashal, Boileau, Isabelle, Le Foll, Bernard, Carvalho, Andre F., Kloiber, Stefan · 2022 · Brazilian Journal of Psychiatry
Releasing the Full Potential of Cannabis through Biotechnology
Li Li, Shuhao Yu, Jiquan Chen, Chaohua Cheng, Jian Yong Sun, Ying Xu, Canhui Deng, Zhigang Dai, Zemao Yang, Xiaojun Chen et al. · 2022 · Agronomy
Effects of Cannabidiol in Inflammation: A Review of Pre-clinical and Clinical Findings
Michaela Sklenárová, Martin Šíma, Ondřej Slanař · 2023 · Prague Medical Report
Cannabidiol at Nanomolar Concentrations Negatively Affects Signaling through the Adenosine A2A Receptor
Iu Raïch, Jaume Lillo, Carlos Ferreiro‐Vera, Verónica Sánchez de Medina, Gemma Navarro, Rafael Franco · 2023 · International Journal of Molecular Sciences
Unraveling the Mechanisms of Cannabidiol’s Pharmacological Actions: A Comprehensive Research Overview
Iqra Kalsoom, Kiran Shehzadi, Hansheng Li, Hongliang Wen, Mingjia Yu · 2024 · Topics in Current Chemistry